← All indications
Dysmenorrhea
Painful menstruation.
Drugs by status
Approved for this indication (15)
Phase 4 trials (18)
Phase 3 trials (16)
Phase 2 trials (14)
Organizations
Organization Involved with Phase 4 Indications (20)
- Merck
- Pfizer
- Sanofi
- Sanofi-Aventis
- Bayer
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Fundação Educacional Serra dos Órgãos
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Adana Numune Training and Research Hospital
- Akdeniz University
- Cairo University
- Mahidol University
- Northwestern University
- Pamukkale University
- University of Athens
- University of Chicago
- Vanderbilt University
- Beijing Bionovo Medicine Development Co., Ltd.
- Chinese Academy of Medical Sciences
Organization Involved with Phase 3 Indications (14)
- AbbVie
- Grunenthal
- GlaxoSmithKline
- Daewon Pharmaceutical Co., Ltd.
- Duramed Research
- Nobel Pharmaceuticals
- Mansoura University
- University of British Columbia
- Tottori University
- St. Luke's International Hospital
- State University of New York, Brooklyn
- Nissay Hospital, Osaka
- Bezmialem University
- Bezmialem Vakif University
Organization Involved with Phase 2 Indications (16)
- Wyeth
- Juniper Pharmaceuticals, Inc.
- Boehringer Ingelheim
- Isifer AB
- Vantia Ltd
- Danderyds Hospital
- Jean Brown Research
- Assiut University
- Karolinska Institute
- Premier Research Group
- Pennsylvania State University
- Bio-Kinetic Clinical Applications
- Pivotal Research Centers
- Biokey Inc.
- Government of Sweden
- Pure Green, LLC
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (8)